Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
HCA
Strong BuyUnloved QualityFLAGHCA Healthcare, Inc. · Healthcare · United States · $90.5B · Avg Vol: $545M/d
HCA Healthcare has strong quality Q78 and value V65 with a buyback retiring 4.92% of shares outstanding, substantial corroboration, but momentum at M38 is below the calibrated floor, so stage one fails, consistent with the Mexican line flagged earlier in this run.
COMPANY DESCRIPTION
HCA Healthcare, Inc. is one of the largest for-profit healthcare providers in the United States, operating an extensive network of hospitals, freestanding surgery centers, and other care facilities. The company benefits from its significant scale, strategic geographic concentration in high-growth markets, and an integrated care delivery system that drives operational efficiencies. This enables it to offer comprehensive medical services while maintaining a strong market position.
FINANCIAL SUMMARY (USD)
| Year | 2022 | 2023 | 2024 | 2025 | CAGR | TTM | 2026E | 2027E | Fwd CAGR |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 60.2B | 65.0B | 70.6B | 75.6B | 7.9% | 78.0B | 78.5B | 81.6B | 3.9% |
| EPS | 19.43 | 19.74 | 23.04 | 28.70 | 13.9% | 29.83 | 30.00 | 32.62 | 6.6% |
| Shares | 277.4M | 265.5M | 250.0M | 224.6M | -19.0% | 216.5M | — | — | — |
| Debt | 40.2B | 41.9B | 45.2B | 48.7B | 6.6% | 51.6B | — | — | — |
| Equity | -2.8B | -1.8B | -2.5B | -6.0B | — | — | — | — | — |
| Op CF | 8.5B | 9.4B | 10.5B | 12.6B | 14.0% | 11.1B | — | — | — |
| Inv CF | -3.4B | -5.3B | -4.9B | -5.0B | — | — | — | — | — |
| Fin CF | -5.7B | -4.1B | -4.6B | -8.6B | — | — | — | — | — |
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of HCA are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| HCA | HCA Healthcare, Inc.(you) | $90.5B | 85 | Strong Buy |
| FRE.DE | Fresenius SE & Co. KGaA | $25.5B | 83 | Strong Buy |
| RDOR3.SA | Rede D'Or São Luiz S.A. | $14.8B | 85 | Strong Buy |
| THC | Tenet Healthcare Corporation | $21.5B | 98 | Strong Buy |
| EHC | Encompass Health Corporation | $11.9B | 91 | Strong Buy |
| UHS | Universal Health Services, Inc. | $10.1B | 89 | Strong Buy |
| DVA | DaVita Inc. | $11.5B | 92 | Strong Buy |
| FME.DE | Fresenius Medical Care AG | $12.3B | 94 | Strong Buy |
| BDMS.BK | Bangkok Dusit Medical Services Public Company Limited | $9.7B | 79 | Buy |
| RHC.AX | Ramsay Health Care Limited | $8.5B | 81 | Strong Buy |
Peer medians: ROE 2.9% · P/E 24.4x · Gross margin 52.5%